Radioimmunodetection and Radioimmunotherapy of Breast Cancer

Bischof Delaloye A. , Delaloye B. : Tumor imaging with monoclonal antibodies. Sem. Nucl. Med., 25, 144–164, 1995.

Buckman R. , De Angelis C. , Shaw P. , Covens A. , Osborne R. , Kerr I. : Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3. Gynecol. Oncol., 47: 102–109, 1992.

Chung J.K. , Jang J.J. , Lee D.S. , Lee M.C. , Koh C.S. : Tumor concentration and distribution of carcinoembryonic antigen measured by in vitro quantitative autoradiography. J. Nucl. Med., 35: 1499–1505, 1994.

Colcher M. , Roselli M. , Carrasquillo J.A. , Reynolds J.C. , Larson S.M. , Sugarbaker P. , Tuttle S.E. , Martin E.W. : Tumor targeting with monoclonal antibody B72.3. Nucl. Med. Biol., 16: 137–142, 1989.

Contegiacomo A. , Alimandi M. , Muraro R. , Pizzi C. , Calderopoli R. , De Marchis L. , Sgambato A. , Pettinato G. , Petrella G. , De Filippo M.R. : Expression of epitopes of the tumour-associated glycoprotein 72 and clinical-pathological correlations in mammary carcinomas. Eur. J. Cancer, 30A: 813–820, 1994.

De Nardo G. , De Nardo S. , Kukis D. , Diril H. , Suey C. , Meares C. : Strategies for enhancement of radioimmunotherapy. Nucl. Med. Biol., 18: 633–639, 1991.

De Nardo S. , Krainer E.L. , Richam C.M. , Salako Q.A. , Perez E.A. , O'Grady L.F. :Radioimmunotherapy of breast cancer with Y-90/In-111 BrE-3: current clinical results and therapeutic potential. J. Nucl. Med, 34: 53P, 1993.

De Nardo S. , O'Grady L.F. , Richman C.M. , De Nardo G. : Overview of radioimmunotherapy in advanced breast cancer using 1–131 chimeric L6. Adv. Exp. Med. Biol., 353: 203–211, 1994.

Goodman G.E. , Hellstrom I. , Yelton D.E. , Murray J.L. , O'Hara S. , Meaker E. , Zeigler L. , Palazollo P. , Nicaise C. , Usakewicz J. : Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer. Cancer Immunol. Immunother., 36: 267–273, 1993.

Guadagni F. , Roselli M. , Nieroda C. , Dansky-Ullmann G. , Schlom J. , Greiner J.W. : Biological response modifiers as adjuvants in monoclonal antibody based treatment in vivo, 7: 591–599, 1993.

Guadagni F. , Roselli M. , Schlom J. , Greiner J.W. : In vitro and in vivo regulation of human tumor antigen expression by human recombinant interferons: a review. Int. J. Biol. Markers, 9: 53–60, 1994.

Hird V. , Snook C. , Kosmas B. , Dhokia S. , Stewart P. , Mason J. , Lambert C. , Meares C. , Epenetos A. : Intraperitoneal radioimmunotherapy with yttrium-90 labeled immunoconjugates in monoclonal antibodies application in oncology (ed. Epenetos A. ). Chapman and Hall, London, pp. 267–271, 1991.

Kelsey J. (Ed.) Breast cancer, Epidemiology Reviews. Vol. 15, n. 1, 1993.

Kalofonos H.P. , Kosmas C. , Hird V. , Snook D.E. , Epenetos A.A. : Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response. Eur. J. Cancer, 30A: 1842–1850, 1994.

Lind P. , Lechner P. , Ratschek M. , Klima G. , Koltringer P. , Steindorfer P. , Eber O. : The immunoscintigraphic use of Tc99m-labeled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer. Int. J. Cancer, 46: 865–869, 1991.

Loevinger R. , Berman M. : A schema for absorbed dose calculation for biologically distributed radionuclides. Pamphlet n. 1, J. Nucl. Med., 9 (suppl. 1): 7–14, 1968.

Leung S.O. , Karacay H. , Losman M.J. , Griffiths G.L. , Goldenberg D.M. , Hansen H.J. :Bacterial expression of a kemp-tide fusion protein facilitates 32P labeling of a humanized anti-carcinoembryonic antigen (hMN-14) antibody fragment. Cancer Res., 55: 5968s–5972s, 1995.

MIRD Pamphlet, n. 11. The Society of Nuclear Medicine, N.Y., 1985.

Paganelli G. , Pervez S. , Siccardi A.G. , Rowlinson G. , Deleide G. , Chiolerio F. , Malcavati M. , Scassellati G.A. , Epenetos A.A. : Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies. Int. J. Cancer, 45: 1184–1189, 1990.

Riva P. , Moscatelli G. , Paganelli G. , Benini S. , Siccardi A. : Antibody guided tumor diagnosis: an Italian experience on CEA-expressing tumors. Int. J. Cancer, Supplement 2: 114–120, 1988.

Schier D.M. , Stemmer S.M. , Johnson T. , Kasliwal R. , Lear J.S. : High-dose 90Y Mx-diethylelenetriaminepentaacetic acid (DTPA-BrE-3) and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial: Cancer Res., 55: 5921s–5924s, 1995.

Schlom J. , Molinolo A. , Simpson J.F. , Siler K. , Roselli M. , Hiffide G. : Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy. J. Natl. Cancer Inst., 82: 763–771, 1990.

Schlom J. , Siler K. , Milenic D.E. , Eggensperger D. , Colcher D. , Miller L.S. , Houchens D. , Cheng R. , Kaplan D. , Goeckeler W. : Monoclonal antibody-based therapy of a human tumor xenograft with a 177-lutetium-labeled immunoconjugate. Cancer Res., 51: 2889–2896, 1991.

Seccamani E. , Tattanelli M. , Mariani M. , Spranzi E. , Scassellati G.A. , Siccardi A.G. : A simple qualitative determination of human antibodies to murine immunoglobulins (HAMA) in serum samples. Nucl. Med. Biol., 16: 167–170, 1989.

Sharkey R.M. , Juweid M. , Shevitz J. , Behr T. , Dunn R. , Swayne L.C. , Wong G.Y. , Blumenthal R.D. , Griffiths G.I. , Siegel J.A. , Leung S. , Hansen H.J. , Goldenberg D.M. :Evaluation of a complementarity-determining region-grafted (humanized) anticarcinoembryonic antigen monoclonal antibody in preclinical and clinical studies. Cancer Res., 55: 5935s–5945s, 1995.

Siccardi A.G. , Buraggi G.L. , Callegaro L. , Centi Colella A. , De Filippi P.G. , Galli G. , Mariani G. , Masi R. , Palumbo R. , Riva P. : Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicentre study. Cancer Res., 49: 3095–3103, 1989.

Stickney D.R. , Gridley D.S. , Kirk G.A. , Slater J.M. : Enhancement of monoclonal antibody binding to melanoma with single dose radiation or hyperthermia. Natl. Cancer Inst. Monogr., 3: 47–52, 1985.

Tjandra J.J. , Sacks N.P. , Thompson C.H. , Leyden M.J. , Andrews M.J. , Pietersz G.A. : The detection of axillary lymph node metastases from breast cancer by radiolabeled monoclonal antibodies: a prospective study. Br. J. Cancer, 59: 296–302, 1989.

Thor A.D. , Edgerton S.M. Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications. Semin. Nucl. Med., 19: 295–308, 1989.